SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067057
Filing Date
2017-11-09
Accepted
2017-11-08 17:39:09
Documents
71
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20656_110q.htm 10-Q 1158619
2 EX-31.1 a17-20656_1ex31d1.htm EX-31.1 9665
3 EX-31.2 a17-20656_1ex31d2.htm EX-31.2 9709
4 EX-32.1 a17-20656_1ex32d1.htm EX-32.1 6153
5 EX-32.2 a17-20656_1ex32d2.htm EX-32.2 6172
  Complete submission text file 0001104659-17-067057.txt   5690967

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20170930.xml EX-101.INS 1310848
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20170930.xsd EX-101.SCH 45005
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20170930_cal.xml EX-101.CAL 66933
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20170930_def.xml EX-101.DEF 128275
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20170930_lab.xml EX-101.LAB 425403
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20170930_pre.xml EX-101.PRE 288736
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 171187678
SIC: 2834 Pharmaceutical Preparations